v3.23.3

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 84,551	$ 121,859
Prepaid Expenses	10,770	5,925
Total assets	95,321	127,784
Current liabilities
Customer advances	10,007	99,599
Accounts payable	6,025	6,130
Accrued liabilities	3,419	2,739
Other payables	239
Tax payable	21,533
Total liabilities	63,585	108,468
Commitments and Contingencies
Stockholders’ Equity
Preferred stock, $0.0001 par value, 30,000,000 shares authorized, no shares issued and outstanding as of September 30, 2023 and December 31, 2022
Common stock, $0.0001 par value, 320,000,000 shares authorized, 42,959,574 shares issued and outstanding as of September 30, 2023 and December 31, 2022	4,296	4,296
Additional Paid in Capital	360,330	360,330
Accumulated deficit	(332,890)	(345,310)
Total stockholders’ equity	31,736	19,316
Total liabilities and stockholders’ deficit	95,321	127,784
Related Party [Member]
Current liabilities
Due to Related Party Payable	$ 22,362

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

NP Life Sciences Health Industry Group Inc. 10-Q